All nine macaques given the control developed severe disease when exposed to bird flu, as did all given the smallest dose of protective antibody. When macaques were given 10 milligrams or 30 milligrams of the antibody per kilogram of body weight, however, none of them developed severe disease.
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.
A prophylactic antibody-based immune therapy protects monkeys against severe disease caused by H5N1 avian flu, University of Pittsburgh and NIH Vaccine Research Center researchers report today in Science.
Sec. Mike Naig says the U.S. government is using what he describes as a three-legged stool approach to address the virus in the dairy and poultry industries.
Health authorities need to be concerned about bird flu, but the risk to the public is low. You’re reading The Checkup With Dr. Wen, a newsletter on how to navigate medical and public health challenges. Click here to get the full newsletter in your inbox, including answers to reader questions and a summary of new scientific research.
The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains with pandemic potential.
Are eggs safe to eat amid the current avian flu outbreak? Have people in the U.S. contracted bird flu? We VERIFY the answers to common questions.
The number of bird flu cases in Central Massachusetts is relatively low, compared to a swath of the state that runs from Greater Boston to Southeastern Massachusetts. That message was delivered Wednesday during a virtual update from state health officials on the highly pathogenic avian influenza H5N1 virus.
The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.
The money "allows Moderna to accelerate development of an H5N1 mRNA influenza vaccine that is well matched to strains currently circulating in cows and birds." This is in addition to the $176 million Moderna was awarded in July 2024. And on Thursday the US ...
The H5N1 detection in a human is the UK’s first since 2023 when surveillance detected infections in poultry workers. Regarding the new case, the HSA said the patient is from the West Midlands region and that the patient is well and has been admitted to a high consequence infectious disease unit.
Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats. Others, including GSK and Pfizer, are also at work on similar shots.